Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other Symptoms December 7, 2020
GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patients November 30, 2020
Alnylam, founded by Christoph Westphal as CEO, scores European approval for rare disease med Oxlumo November 20, 2020
TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response November 17, 2020
